Winshine Science Co (HKSE:00209) Quality Rank

View and export this data going back to 2002. Start your Free Trial

What is Winshine Science Co Quality Rank?

The Quality Rank measures the business quality of a company relative to other companies. It is ranked based on the strength of the balance sheet, as well as the profitability and growth of the business. The ranked companies are split in equal numbers and then ranked from 1 to 10, with 10 being the highest.

The rank of balance sheet (30%)

The rank of balance sheet is done through the ranking of:

Interest coverage
Zscore
Debt to revenue
Equity to asset
Cash to debt

The rank of Profitability (70%)

The ranking of Profitability is done by ranking:

Operating margin mean rank (10-year mean average profit margine)
Operating margin growth rank
Fscore
Predictability rank
Revenue growth rank (5 year), when the growth is higher than 25%, set it as 25%
Num of year profit (number of years that is profitable within the last 10 years)
ROIC median (10-year median of ROIC)

Winshine Science Co Quality Rank Related Terms

Thank you for viewing the detailed overview of Winshine Science Co's Quality Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Winshine Science Co (HKSE:00209) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Travel & Leisure » Winshine Science Co Ltd (HKSE:00209) » Definitions » Quality Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

287-299 Queen's Road, Room 1002, 10th Floor, 299 QRC, Central, Hong Kong, HKG

Website

http://www.winshine.com

Winshine Science Co Ltd is an investment holding company. The company's segment includes Securities investments, Toys, and Medical & health. It generates maximum revenue from the Toys segment. The toys segment derives its revenue from manufacturing for the sale of toys. The securities investments segment derives its profits or losses from dividends received from, and other gains or losses from, equity securities investments. The medical and health segment is under the development stage in which research and development expenses for medical and health technology development have been incurred. Its geographical segments are Hong Kong, China, the United States, Europe, and Korea, of which the majority of its revenue comes from the United States.

Executives

Wang Honggang	2101 Beneficial owner
U Credit (hk) Limited	2106 Person having a security interest in shares
Csc Holdings Limited	2106 Person having a security interest in shares
Hurray Talent Investment Development Limited	2101 Beneficial owner
Li Zhonghai	2201 Interest of corporation controlled by you
Liu Lian	2201 Interest of corporation controlled by you
Richsun Investment Development Limited	2101 Beneficial owner
Hong Kong Huiheng Trading And Investment Co., Limited	2101 Beneficial owner
Jiang Qinghui	2201 Interest of corporation controlled by you
Csc Holdings Limited (formerly Known As "china Strategic Holdings Limited")	2106 Person having a security interest in shares
China Strategic Holdings Limited	2106 Person having a security interest in shares
Shen Jia	2101 Beneficial owner